Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cardiac Resynchronization Therapy (CRT) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global cardiac resynchronization therapy (CRT) market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Cardiac resynchronization therapy (CRT), or biventricular pacing, refers to a therapeutic procedure to correct or facilitate synchronized beating of the right and left ventricle of the heart. This therapy aids in improving the functioning of the heart, increasing the blood flow and facilitating faster recovery of the patient. It involves the use of a defibrillator to generate a pulse and thin insulated wires or leads to send electric impulses into the lower chambers of the heart. The device is surgically implanted and is connected to an external computer for periodic monitoring of the heart. It sends small electrical impulses to the left and right ventricles to support contraction at the same time.

The increasing prevalence of cardiovascular diseases (CVDs) across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to ailments such as arrhythmias, congenital heart disease and atrial fibrillation, is providing a thrust to the market growth. In line with this, increasing health consciousness and awareness regarding the available treatment alternatives for heart-related ailments is also contributing to the market growth. Various technological advancements, such as the development of MRI-safe and wireless CRT devices, are acting as other growth-inducing factors. These novel systems aid in optimizing CRT programming and multipoint pacing to promote the healthy activity of the heart. Other factors, including increasing healthcare expenditures capacities of the individuals, along with improvements in the healthcare infrastructure, especially in the developing nations, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac resynchronization therapy (crt) market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, application and end user.

Breakup by Type:

  • CRT-Defibrillator
  • CRT-Pacemaker
     

Breakup by Application:

  • Intraventricular Dyssynchrony
  • Interventricular (V-V) Dyssynchrony
  • Atrioventricular (A-V) Dyssynchrony
     

Breakup by End User:

  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgery Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Inc. and MicroPort Scientific Corporation.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Inc. and MicroPort Scientific Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cardiac resynchronization therapy (CRT) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cardiac resynchronization therapy (CRT) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cardiac resynchronization therapy (CRT) market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cardiac Resynchronization Therapy (CRT) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    CRT-Defibrillator
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    CRT-Pacemaker
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Application
    7.1    Intraventricular Dyssynchrony
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Interventricular (V-V) Dyssynchrony
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Atrioventricular (A-V) Dyssynchrony
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiac Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Ambulatory Surgery Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials 
           14.3.1.4 SWOT Analysis
        14.3.2    Biotronik SE & Co. KG
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials 
           14.3.2.4 SWOT Analysis
        14.3.3    Boston Scientific Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials 
           14.3.3.4 SWOT Analysis
        14.3.4    LivaNova Plc
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials 
        14.3.5    Medico S.p.A.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials 
        14.3.6    Medtronic Plc
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merit Medical Systems Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials 
           14.3.7.4 SWOT Analysis
        14.3.8    MicroPort Scientific Corporation
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 

List of Figures

Figure 1: Global: Cardiac Resynchronization Therapy Market: Major Drivers and Challenges
Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2020
Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2020
Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2020
Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2020
Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Spain: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Spain: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Cardiac Resynchronization Therapy Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Cardiac Resynchronization Therapy Market Structure
Table 7: Global: Cardiac Resynchronization Therapy Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links